Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Prognostic value of circulating microRNA-210 levels in patients with moderate to severe aortic stenosis.

Røsjø H, Dahl MB, Bye A, Andreassen J, Jørgensen M, Wisløff U, Christensen G, Edvardsen T, Omland T.

PLoS One. 2014 Mar 13;9(3):e91812. doi: 10.1371/journal.pone.0091812. eCollection 2014.

2.

Circulating level of miR-378 predicts left ventricular hypertrophy in patients with aortic stenosis.

Chen Z, Li C, Xu Y, Li Y, Yang H, Rao L.

PLoS One. 2014 Aug 26;9(8):e105702. doi: 10.1371/journal.pone.0105702. eCollection 2014.

3.

Circulating levels of miR-133a predict the regression potential of left ventricular hypertrophy after valve replacement surgery in patients with aortic stenosis.

García R, Villar AV, Cobo M, Llano M, Martín-Durán R, Hurlé MA, Nistal JF.

J Am Heart Assoc. 2013 Aug 15;2(4):e000211. doi: 10.1161/JAHA.113.000211.

4.

Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients.

Villar AV, García R, Merino D, Llano M, Cobo M, Montalvo C, Martín-Durán R, Hurlé MA, Nistal JF.

Int J Cardiol. 2013 Sep 10;167(6):2875-81. doi: 10.1016/j.ijcard.2012.07.021. Epub 2012 Aug 9.

PMID:
22882958
5.

MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease.

Jansen F, Yang X, Proebsting S, Hoelscher M, Przybilla D, Baumann K, Schmitz T, Dolf A, Endl E, Franklin BS, Sinning JM, Vasa-Nicotera M, Nickenig G, Werner N.

J Am Heart Assoc. 2014 Oct 27;3(6):e001249. doi: 10.1161/JAHA.114.001249.

6.

Circulating miR-323-3p and miR-652: candidate markers for the presence and progression of acute coronary syndromes.

Pilbrow AP, Cordeddu L, Cameron VA, Frampton CM, Troughton RW, Doughty RN, Whalley GA, Ellis CJ, Yandle TG, Richards AM, Foo RS.

Int J Cardiol. 2014 Sep 20;176(2):375-85. doi: 10.1016/j.ijcard.2014.07.068. Epub 2014 Jul 22.

PMID:
25124998
7.

Circulating microRNA Profiling Needs Further Refinement Before Clinical Use in Patients With Aortic Stenosis.

Coffey S, Williams MJ, Phillips LV, Jones GT.

J Am Heart Assoc. 2015 Aug 24;4(8):e002150. doi: 10.1161/JAHA.115.002150.

8.

Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.

Derda AA, Thum S, Lorenzen JM, Bavendiek U, Heineke J, Keyser B, Stuhrmann M, Givens RC, Kennel PJ, Schulze PC, Widder JD, Bauersachs J, Thum T.

Int J Cardiol. 2015 Oct 1;196:115-22. doi: 10.1016/j.ijcard.2015.05.185. Epub 2015 Jun 5.

9.

Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients.

Ellis KL, Cameron VA, Troughton RW, Frampton CM, Ellmers LJ, Richards AM.

Eur J Heart Fail. 2013 Oct;15(10):1138-47. doi: 10.1093/eurjhf/hft078. Epub 2013 May 21.

10.

Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients.

Teixeira AL, Ferreira M, Silva J, Gomes M, Dias F, Santos JI, Maurício J, Lobo F, Medeiros R.

Tumour Biol. 2014 May;35(5):4057-66. doi: 10.1007/s13277-013-1531-3. Epub 2013 Dec 31.

PMID:
24379138
11.

Predictive value of circulating miR-328 and miR-134 for acute myocardial infarction.

He F, Lv P, Zhao X, Wang X, Ma X, Meng W, Meng X, Dong S.

Mol Cell Biochem. 2014 Sep;394(1-2):137-44. doi: 10.1007/s11010-014-2089-0. Epub 2014 May 16.

PMID:
24833470
12.

Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction.

Gidlöf O, Smith JG, Miyazu K, Gilje P, Spencer A, Blomquist S, Erlinge D.

BMC Cardiovasc Disord. 2013 Feb 28;13:12. doi: 10.1186/1471-2261-13-12.

13.

Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer.

Fu Z, Qian F, Yang X, Jiang H, Chen Y, Liu S.

Med Oncol. 2014 Sep;31(9):164. doi: 10.1007/s12032-014-0164-8. Epub 2014 Aug 17.

PMID:
25129310
14.

A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.

Lin XJ, Chong Y, Guo ZW, Xie C, Yang XJ, Zhang Q, Li SP, Xiong Y, Yuan Y, Min J, Jia WH, Jie Y, Chen MS, Chen MX, Fang JH, Zeng C, Zhang Y, Guo RP, Wu Y, Lin G, Zheng L, Zhuang SM.

Lancet Oncol. 2015 Jul;16(7):804-15. doi: 10.1016/S1470-2045(15)00048-0. Epub 2015 Jun 15.

PMID:
26088272
15.

Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.

Wu C, Wang C, Guan X, Liu Y, Li D, Zhou X, Zhang Y, Chen X, Wang J, Zen K, Zhang CY, Zhang C.

PLoS One. 2014 Mar 20;9(3):e92292. doi: 10.1371/journal.pone.0092292. eCollection 2014.

16.

MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.

Lee JC, Zhao JT, Clifton-Bligh RJ, Gill A, Gundara JS, Ip JC, Glover A, Sywak MS, Delbridge LW, Robinson BG, Sidhu SB.

Cancer. 2013 Dec 15;119(24):4358-65. doi: 10.1002/cncr.28254. Epub 2013 Oct 28.

17.

Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.

Wang Y, Gao X, Wei F, Zhang X, Yu J, Zhao H, Sun Q, Yan F, Yan C, Li H, Ren X.

Gene. 2014 Jan 1;533(1):389-97. doi: 10.1016/j.gene.2013.09.038. Epub 2013 Sep 26. Review.

PMID:
24076132
18.

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma.

Köberle V, Kronenberger B, Pleli T, Trojan J, Imelmann E, Peveling-Oberhag J, Welker MW, Elhendawy M, Zeuzem S, Piiper A, Waidmann O.

Eur J Cancer. 2013 Nov;49(16):3442-9. doi: 10.1016/j.ejca.2013.06.002. Epub 2013 Jun 26.

PMID:
23810247
19.

Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer.

Valladares-Ayerbes M, Reboredo M, Medina-Villaamil V, Iglesias-Díaz P, Lorenzo-Patiño MJ, Haz M, Santamarina I, Blanco M, Fernández-Tajes J, Quindós M, Carral A, Figueroa A, Antón-Aparicio LM, Calvo L.

J Transl Med. 2012 Sep 6;10:186. doi: 10.1186/1479-5876-10-186.

20.

Circulating miR-148a is a significant diagnostic and prognostic biomarker for patients with osteosarcoma.

Ma W, Zhang X, Chai J, Chen P, Ren P, Gong M.

Tumour Biol. 2014 Dec;35(12):12467-72. doi: 10.1007/s13277-014-2565-x. Epub 2014 Sep 4.

PMID:
25185654
Items per page

Supplemental Content

Write to the Help Desk